Castle Biosciences, Inc. Share Price
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
01:30:00 02/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 35.26 USD | -0.77% |
|
+0.18% | -9.37% |
| Market Cap | 107.7Cr 96Cr 89Cr 82Cr 153.48Cr 10TCr 155.59Cr 1.08TCr 418.95Cr 5.28TCr 404.37Cr 395.6Cr 17TCr | P/E 2026 * |
-27.8x | P/E 2027 * | -37.5x |
|---|---|---|---|---|---|
| Enterprise Value | 107.7Cr 96Cr 89Cr 82Cr 153.48Cr 10TCr 155.59Cr 1.08TCr 418.95Cr 5.28TCr 404.37Cr 395.6Cr 17TCr | EV / Sales 2026 * |
2.89x | EV / Sales 2027 * | 2.62x |
| Free-Float |
97.58% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CSTL | Delayed | |
CBOE
| CSTL | Real-time | |
|
Tradegate
| 086 | Real-time | |
|
Deutsche Boerse AG
| 086 | Delayed | |
|
Deutsche Boerse AG
| 086 | End-of-day quote |
Last Transcript: Castle Biosciences, Inc.
| 1 day | -0.77% | ||
| 1 week | +0.18% | ||
| Current month | -0.77% | ||
| 1 month | +5.43% | ||
| 3 months | +42.68% | ||
| 6 months | +40.74% | ||
| Current year | -9.37% |
| 1 week | 34.14 |  | 36.99 |
| 1 month | 31.44 | | 36.99 |
| Current year | 17.72 | | 44.28 |
| 1 year | 17.72 | | 44.28 |
| 3 years | 12.07 | | 44.28 |
| 5 years | 9.26 | | 68.65 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 01/09/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 01/12/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 01/09/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 01/09/2014 |
G. Cole
BRD | Director/Board Member | 70 | 06/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/26 | Exercice | Founder | 31,656 | 0.1036% | ||
| 15/09/26 | Sell | Executive/Senior Manager | -3,294 | 0.0108% | ||
| 11/09/26 | Exercice | Founder | 31,686 | 0.1037% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | +0.18% | +53.15% | +108.73% | 107.7Cr | |
| -2.17% | -4.33% | -27.56% | -0.17% | 17TCr | |
| +0.17% | -2.34% | -8.83% | +10.31% | 11TCr | |
| -0.88% | +1.19% | -25.04% | -0.11% | 10TCr | |
| +0.48% | +0.97% | -48.14% | -11.22% | 7.48TCr | |
| +3.17% | -0.03% | -0.64% | +72.13% | 5.91TCr | |
| -0.86% | +2.96% | +13.57% | +59.50% | 5.18TCr | |
| -0.52% | -0.65% | -6.74% | -31.12% | 4.85TCr | |
| -0.85% | +0.85% | -16.51% | +18.41% | 4.08TCr | |
| -0.07% | -1.42% | +30.49% | -7.58% | 3.25TCr | |
| Average | +0.24% | -0.12% | -3.62% | +21.89% | 6.91TCr | |
| Weighted average by Cap. | +0.64% | -0.91% | -16.05% | +9.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37Cr 33Cr 31Cr 28Cr 53Cr 3.59TCr 54Cr 374.98Cr 145.16Cr 1.83TCr 140.11Cr 137.07Cr 5.88TCr | 41Cr 37Cr 34Cr 31Cr 59Cr 3.96TCr 59Cr 413.62Cr 160.12Cr 2.02TCr 154.54Cr 151.19Cr 6.48TCr |
| Net income | -3.78Cr -3.36Cr -3.14Cr -2.86Cr -5.38Cr -363.78Cr -5.46Cr -38Cr -15Cr -185.27Cr -14Cr -14Cr -595.06Cr | -2.56Cr -2.28Cr -2.13Cr -1.94Cr -3.65Cr -246.88Cr -3.7Cr -26Cr -9.97Cr -125.73Cr -9.63Cr -9.42Cr -403.84Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | $35.26 | -0.77% | 5,22,290 |
| 30/26/30 | $35.53 | +1.86% | 6,39,605 |
| 29/26/29 | $34.88 | -2.92% | 3,18,619 |
| 28/26/28 | $35.93 | +0.34% | 2,28,425 |
| 25/26/25 | $35.81 | +1.76% | 4,37,681 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
